Genetic factors influencing the metabolism of tolbutamide

This publication has 34 references indexed in Scilit:

• In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
  British Journal of Clinical Pharmacology, 1988
• Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide
  European Journal of Clinical Pharmacology, 1988
• Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine
  The Journal of Clinical Pharmacology, 1986
• Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat
  British Journal of Pharmacology, 1984
• Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline‐sulphinpyrazone interaction.
  British Journal of Clinical Pharmacology, 1983
• Effects of total plasma concentration and age on tolbutamide plasma protein binding
  Clinical Pharmacology & Therapeutics, 1982
• Clinical Pharmacokinetics of Sulphonylurea Hypoglycaemic Drugs
  Clinical Pharmacokinetics, 1981
• Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection
  Diabetes, 1977
• Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration
  Clinical Pharmacology & Therapeutics, 1974
• SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS
  The Lancet, 1963